Retratitida caneta 40mg
Retatrutida is a medication designed for obesity and type 2 diabetes treatment. It acts on GIP, GLP-1, and glucagon receptors to control energy metabolism and blood glucose levels, potentially reducing appetite and increasing metabolic rate.
- The description claims that Retatrutida reduces appetite and increases metabolic rate.
- The description claims that Retatrutida promotes insulin release and improves peripheral insulin sensitivity.
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
66%